Início » Detalhes
Capa:

Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: a case report and review of the literature.

Autor(es)
ImprentaLeukemia Research, v. 34, n. 7, p. 154-156, 2010
Identificador do Objeto Digital10.1016/j.leukres.2010.02.036
DescritoresGuillain-Barre Syndrome - Cell ; Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies ; Guillain-Barre Syndrome - Autoimmunity ; Guillain-Barre Syndrome - Immunology
Data de Publicação:2010